Drug recall · November 4, 2026
Abiraterone Acetate Tablets USP 500 mg recall
Why: Labeling: Not Elsewhere Classified
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60
- Lots / codes
Lot #: 13250135, Exp. Date 11/2027
- Quantity
- 1296 bottles
- Company
- Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ
- Distribution
- Nationwide within the United States
- Initiated
- October 9, 2026 · Voluntary: Firm initiated
- Classified
- October 23, 2026
- Reported
- November 4, 2026
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Abiraterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.